Meta's push into prescription-first smart glasses sent its stock climbing as investors bet on the company's strategy to transform AI eyewear from niche gadget to everyday essential. The social media giant launched two new Ray-Ban smart glasses designed specifically for prescription users, marking a departure from previous models that merely accommodated corrective lenses as an afterthought.
Built from the ground up for vision correction, the "Scriber" and "Blazer" models will be sold through traditional optical stores rather than consumer electronics retailers.
Meta's stock gained ground following the announcement, with shares rising approximately 3% to around $554 in Tuesday trading. The move comes as the company seeks to expand beyond its core advertising business into hardware categories where it can use its AI expertise.
"Billions of people wear glasses or contacts for vision correction," he noted, adding that "it's hard to imagine a world in several years where most glasses that people wear aren't AI glasses."
The prescription-first approach targets the vast majority of eyewear users who require vision correction rather than treating them as a secondary market. The new models maintain the signature Ray-Ban styling while packing AI capabilities directly into frames built for all-day wear. They include a 12-megapixel camera for photos and videos, built-in speakers for calls and music, and hands-free voice control through Meta's AI assistant.
Technical filings with the Federal Communications Commission reveal upgrades including support for Wi-Fi 6 UNII-4 band connectivity, a feature absent from current models. The "Blazer" variant will be available in larger sizes to accommodate more users.
Meta's partnership with EssilorLuxottica, which owns Ray-Ban and other eyewear brands, positions the company to distribute through established optical channels worldwide. The social media firm invested $3.5 billion for a 3% stake in EssilorLuxottica in June 2025, shortly before launching its first display-equipped smart glasses.
The prescription-focused launch follows strong sales of earlier models, with Meta reporting 7 million smart glasses units sold in 2025 alone. By targeting prescription users directly rather than treating them as an add-on market, Meta aims to accelerate adoption among consumers who already wear corrective lenses daily.
Distribution through optical stores represents a shift from consumer electronics retail channels. EssilorLuxottica plans to sell the glasses alongside traditional prescription eyewear at opticians and specialized stores globally.
The move comes amid competition in AI wearables. OpenAI has its smart pendant or speaker scheduled for late 2026, while Apple is reportedly accelerating production of its own smart glasses and other AI wearables.
Google also plans to relaunch its Glass operations with an entirely new design approach.
Even Microsoft, which debuted the first HoloLens improved reality headset in 2015, discontinued production of that device in 2024 in favor of increased investment in cloud and AI services.
Meta's prescription-first strategy could potentially transform smart glasses from specialty gadgets into standard accessories for millions of people who already wear corrective lenses daily.
